Advanced Ultrasound in Diagnosis and Therapy ›› 2021, Vol. 5 ›› Issue (1): 18-25.doi: 10.37015/AUDT.2021.190036

• Review Articles • Previous Articles     Next Articles

Current Status and Advances in Imaging Evaluation of Neoadjuvant Chemotherapy of Breast Cancer

Yixin Hu, MDa, Fei Li, MDa, Jianhua Zhou, MDa,*()   

  1. aDepartment of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
  • Received:2019-11-06 Revised:2020-01-14 Accepted:2020-02-02 Online:2021-03-30 Published:2021-03-25
  • Contact: Jianhua Zhou, MD, E-mail:zhoujh@sysucc.org.cn

Abstract:

It is particularly important to evaluate the efficacy of neoadjuvant chemotherapy (NAC) for breast cancer. This article reviews the current status and progress of imaging evaluations regarding the efficacy of NAC in women with breast cancer, including mammography, ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET-CT) and radiomics. Each imaging method has value for evaluating the efficacy of NAC for breast cancer, but certain defects and limitations. Therefore, the optimal selection will employ a combination of multiple imaging methods that will not only benefit patients but also avoid the unnecessary waste of medical resources.

Key words: Neoadjuvant therapy; Breast neoplasms; Mammography; Ultrasonography; Computed tomography; MRI; PET-CT